Debbie Snyder, M.B.A., R.T., C.L.S. (N.C.A.)
Vice President, Business Development. Debbie Snyder has over 15 years experience in oncology preclinical and clinical activities and is responsible for operational and business activities to support biopharmaceutical clients. Debbie has been with TGen for over three years building infrastructure, business models and partners to share in the translational mission of TGen. Ms. Snyder contributes a broad-ranging academic and professional grounding in immunology, hematology, microbiology and biochemistry with a Medical Laboratory Science background, coupled with an Executive Master of Business Administration degree from Simon Fraser University, Vancouver, Canada. Ms Snyder began her career working in the hospital laboratory, specializing in hematology at the BC Cancer Agency in Vancouver. In 1994, Ms. Snyder accepted a position with a start up biotechnology company, StemCell Technologies Inc. (STI) to establish a quality control department for developing and testing their products. Prior to joining TD2, Ms Snyder held a management position for a publicly traded start up medical device company, VSM MedTech Ltd, where she led cross-functional teams for manufacturing, engineering and sales, and was an integral team member to file, validate and obtain 510K & CE mark submissions.